Bb Biotech | Finanzwire

Basculer en Français

9475	Companies
185451	Keywords
117789	Articles
99301	Press releases

Home
Companies
Bb Biotech

PRESS RELEASE

published on 07/25/2025 at 07:00, 4 months 11 days ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes its interim report for the first half of 2025, showing a net loss and detailing performance of its portfolio stocks

Investment Company Net Loss BB Biotech AG Interim Report Portfolio Stocks
PRESS RELEASE

published on 07/25/2025 at 07:00, 4 months 11 days ago

BB Biotech Q2 2025: outperforms Nasdaq Biotech Index; strong USD returns, currency drag in CHF
BB Biotech AG outperforms Nasdaq Biotech Index in Q2 2025, with strong USD returns but currency drag in CHF. Strategic acquisitions and advancements in portfolio companies drive innovation and value creation

Innovation BB Biotech AG Q2 2025 Nasdaq Biotech Index USD Returns
BRIEF

published on 06/10/2025 at 10:11, 5 months 25 days ago

Edison Releases Report on BB Biotech Amidst Sector Challenges

Investment Strategies Market Volatility Biotech Sector BB Biotech Long-term Outlook
PRESS RELEASE

published on 06/10/2025 at 10:06, 5 months 25 days ago

Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION) covering the recent challenges and opportunities in the biotech sector, including market volatility and long-term outlook

Edison Market Volatility Biotech Sector BB Biotech Long-term Outlook
BRIEF

published on 04/25/2025 at 07:05, 7 months 10 days ago

BB Biotech AG Reports CHF 241 Million Net Loss for Q1 2025

Drug Development Net Loss Investment Portfolio Interim Report BB Biotech
BRIEF

published on 04/25/2025 at 07:05, 7 months 10 days ago

BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market

Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
PRESS RELEASE

published on 04/25/2025 at 07:00, 7 months 10 days ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125

Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE

published on 04/25/2025 at 07:00, 7 months 10 days ago

BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility
BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones

Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF

published on 03/19/2025 at 17:50, 8 months 16 days ago

BB Biotech AG Shareholders Approve Dividend and Re-Elect Board

Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE

published on 03/19/2025 at 17:45, 8 months 16 days ago

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share
Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term

Shareholders Dividend AGM BB Biotech AG Board Proposals

Accesswire

Published on 12/05/2025 at 02:35, 10 hours 5 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 10 hours 10 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 11 hours 40 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 35 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 40 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 12:05, 35 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 40 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 40 minutes ago

Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 26 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 10 minutes ago

Tradegate Exchange and Börse Berlin merge to form Tradegate BSX

Les Echos

Published on 12/05/2025 at 08:45, 3 hours 55 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 40 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 55 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 56 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE